Weight-bearing
Ventilator-associated pneumonia (VAP) is a type of lung infection that occurs in people who are on mechanical ventilation breathing machines in hospitals. As such, VAP typically affects critically ill persons that are in an intensive care unit (ICU).
Causes[edit]
VAP is caused by the invasion of the lower respiratory tract and lung parenchyma by microorganisms. Intubation compromises the integrity of the larynx and of the entire respiratory tree down to the alveoli, which can lead to pneumonia.
Symptoms[edit]
The symptoms of VAP include fever, low body temperature, purulent sputum, and hypoxemia (decreasing amount of oxygen in the blood). Other symptoms may include tachypnea, tachycardia, and changes in blood pressure.
Diagnosis[edit]
The diagnosis of VAP varies from one clinical setting to another but generally includes the presence of a new or progressive infiltrate on a chest X-ray, plus two or more clinical findings such as fever, low body temperature, purulent sputum, leukocytosis, and decline in oxygen status.
Treatment[edit]
The treatment of VAP includes the use of antibiotics. The choice of antibiotic will depend on the identity of the causative organism and its antibiotic susceptibility pattern. In addition to antibiotics, supportive measures such as oxygen, physiotherapy, and in some cases, surgery may be required.
Prevention[edit]
Prevention of VAP involves strategies to reduce the risk of aspiration, to prevent colonization of the aerodigestive tract, to prevent the spread of microorganisms, and to enhance host defenses.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
